Oncology Nutrition Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The oncology nutrition market is expected to register a CAGR of 8.9% over the forecast period.
COVID-19 had a big impact on the market for oncology nutrition. For instance, per the article published in 2022 under the title “Nutrition in Cancer Patients Positive for COVID-19; Case Series and a Systematic Review of Literature”, the study focused on creating recommendations on the nutritional protocol for the management & prevention of complications during ongoing COVID-19 pandemic for all cancer patients. Patients who have cancer are more susceptible to illnesses due to either direct immune system impairment or anticancer medication. Furthermore, as per the article titled “Nutrition and Micronutrients in Cancer Patients Positive for COVID-19” published in 2021, the study showed the importance of diet in the predisposition, prevention, and management of COVID-19 in cancer patients, as well as the role of dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 period. The same source points out the need to develop nutritional maintenance and complication control guidelines for all patients with cancer during the continuing COVID-19 pandemic. Hence due to the aforesaid factors, COVID-19 had a significant impact on the market studied.
The major factors attributing to the growth of the oncology nutrition market are the rising prevalence of cancer cases worldwide. For instance, as per the report from Globocan 2020, the incidence of cancer cases in 2020 was 19.3 million globally. The number is expected to rise to 28.9 million by 2040. The use of nutritional products during and after the treatment of cancer gives the ability to fight disease and offers strength and stamina against the treatment's after-effects which is driving the market growth. And there are a few more factors that are playing crucial roles in taking the oncology nutrition market to the next level, among them increasing demand for nutrition products for oncology in homecare settings and increasing demand for enteral nutrition products are expected to further propel the growth of the oncology nutrition market.
Furthermore, the awareness provided by the government and private agencies is one of the main fuelling factors for market growth. For instance, as per the 2022 update from the American Society of Clinical Oncology (ASCO) Cancer.Net, after cancer treatment is complete, most experts recommend a healthy diet that includes plenty of fruits, vegetables, and whole grains. Moreover, the presence of competitors, new product introductions, and collaborations relating to the market studied, boost the growth of the market. For instance as per the report from 2020, Esperer launched its nutrition development center in Hyderabad, the facility in Hyderabad is anticipated to house a variety of cohesive capabilities including investigative workrooms and product improvement sub-centers with a devoted laboratory for analyzing sensory components, packing, and taste. At the new EsNDC, Esperer is focused and keeps a track of cancer patients to identify dietary changes and assist in creating novel nutrition products and delivery technologies to broaden its existing and future product offerings.
Hence as per the aforementioned factors, the oncology nutrition market is likely to grow over the forecast period. However, the high cost of premium nutrition products for oncology restrains the market growth.
Key Market TrendsLung Cancer is Expected to Witness a Healthy Growth Over the Forecast PeriodThe lung cancer segment is likely to grow during the study period owing to the factors such as the high prevalence of the lung cancer population worldwide, an increase in lung cancer nutritional supplements, and rising awareness and importance of taking nutritional supplements. For instance, as per the report from International Agency for Research on Cancer, the number of people affected by lung cancer was 2.21 million in 2020 and the number is expected to rise to 3.50 million by 2040. As the number of people with cancer increases, the demand for oncology nutrition is likely to upsurge, as nourishment gives the ability to fight disease and offers strength and stamina against the treatment's after-effects.
Furthermore, government initiatives are urging people to have to take proper nutrition while in the cancer treatment and post-treatment. For that purpose, the agencies are relaxing and preparing so many regulations relating to the same. For instance, in May 2021, U.S. Senators Susan Collins (R-ME) and Gary Peters (D-MI) introduced the “Medical Nutrition Therapy Act”, bipartisan legislation that would expand Medicare Part B to cover medical nutrition therapy (MNT) services for additional conditions, including cancer, prediabetes, eating disorders, malnutrition, gastrointestinal diseases (e.g., celiac disease), cardiovascular disease, HIV/AIDS, and other diseases or conditions that cause unintentional weight loss. Such movements are likely to help people financially and motivate them to be keener on taking nutritional supplements thereby boosting the market growth.
Hence as per the factors mentioned above, the lung cancer segment is likely to grow in the oncology nutrition market over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast PeriodNorth America is expected to dominate the overall oncology nutrition market, throughout the forecast period. This is owing to factors such as the rising prevalence of cancer and the availability of advanced healthcare infrastructure among the major factors. For instance, as per the report from the American Cancer Society, the estimated number of new cancer cases is likely to be 1.9 million in the United States. Moreover, government initiatives, product launches, and collaborations in cancer nutrition supplements boost market growth. For instance, the Academy of Nutrition and Dietetics conducted the “2022 Oncology Nutrition Symposium” on June 2022. In the symposium, they discuss the practice of oncology nutrition that covers research, prevention, treatment, recovery, palliative care, and hospice.
Furthermore, the number of cancer cases in Canada was reported as 274,364 in 2020 and the estimated incidence of cancer cases is 373,983 by 2035. The increasing incidence of cancer cases in the region of North America is anticipated to boost market growth. Additionally, a lot of certification programs and awareness classes are conducted regionally to provide education to cancer patients and providers regarding the importance of oncology nutrition. For example, the Oncology Nutrition Institute (ONI) provides evidence-based educational certification and training programs in the field of modern, metabolic, innovative, integrative, and outcomes-based oncology nutrition therapy. Its flagship 250-Hour Oncology Nutrition Consulting (ONC) certification program is an intensive training program designed for qualified nutrition, health, and medical practitioners. Its flagship 250-Hour Oncology Nutrition Consulting (ONC) certification program is an intensive training program designed for qualified nutrition, health, and medical practitioners.
Hence as per the factors mentioned above, North America is expected to witness growth over the forecast period.
Competitive LandscapeThe oncology nutrition market is consolidated and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies and launching new products to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Abbott Laboratories, Nestle S.A., Fresenius Kabi AG, B.Braun Melsungen AG, and Hormel Foods Corporation.
Additional Benefits:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook